Metabolic Solutions Development Company (www.msdrx.com) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company’s lead products, MSDC-0160 and MSDC-0602, are the first anti-diabetic agents in a new class of insulin sensitizers characterized as mTOT Modulators for the treatment of type 2 diabetes.
MSDC is an Equal Opportunity Employer, and prohibits discrimination against applicants for employment, or employees. Any current career opportunities are listed below, but we will appreciate being aware of your interest anytime. Résumés may be submitted in confidence to:
Metabolic Solutions Development Company
161 E Michigan Ave., 4th Floor
Kalamazoo MI 49007